ea0019p357 | Thyroid | SFEBES2009
Panicker V
, Saravanan P
, Vaidya B
, Evans J
, Hattersley A
, Frayling T
, Dayan C
Introduction: There remains considerable debate over combination T4/T3 therapy for thyroid hormone replacement. Whilst large randomised-controlled studies have failed to show benefit over T4 only, there remain patients who feel better on the combination. Animal studies suggest that up to 80% of intracellular T3 in the brain is derived from circulating T4 by local deiodination. We hypothesized that in patients on thyroxine ...